Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous Immunoglobulins for the Treatment of Covid-19 Patients: a Clinical Trial

NCT04548557 is registered in ClinicalTrials.gov with University of Health Sciences Lahore as lead sponsor.

NCT NCT04548557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04548557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous Immunoglobulins for the Treatment of Covid-19 Patients: a Clinical Trial
Lead sponsor
University of Health Sciences Lahore
Phase
Phase 3
Overall status
Unknown status
Start date
September 15, 2020
Completion date
November 15, 2020
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19